维普期刊资源整合服务平台（V6.5）

380篇 您的检索式：作者名="ASA SL"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	2022年WHO甲状腺肿瘤分类概述显示文摘2022年WHO第5版甲状腺肿瘤分类按细胞起源、病理特征、分子分型及生物学行为,分为良性、低危组和恶性。新分类变化不少,作者做了综述。将发育异常甲状舌管纳入;为避免结节性甲状腺肿定义为增生性、肿瘤性或矛盾的“腺瘤样增生”,编委会达成共识,命名为甲状腺滤泡结节性病变(FND)。基于分子谱和侵袭性,多种形态亚型的甲状腺乳头状癌(PTC)代表了BRAF样癌(浸润性生长、核非典型明显);而包裹型浸润性乳头状癌滤泡变异型/[IEFVPC,分子检测证实与滤泡性甲状腺癌(FTC)关系密切,不再归于PTC]与FTC代表RAS样癌(膨胀性生长、核非典型轻度)。	Baloch ZW Asa SL Barletta JA 方三高(译) 魏建国(校)	2022	诊断病理学杂志2022，29，12：	63
2	Pathogenetic mechanism in thyroid follicular-cell neoplasia显示文摘	Kondo T Ezzat S Asa SL	2006	Nat Rev Cancer2006，6，4：	1
3	Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas:relation to tumor type,size,proliferation,and invasiveness显示文摘	Qian ZR Sano T Asa SL	2004	J Clin Endocrinol Metab2004，89，4：	1
4	Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors显示文摘	Cherty R Scrra S Asa SL	2008	Am J Surg Pathol2008，32，3：	1
5	The pathogenes is of pituitary, tumor显示文摘	ASA SL EZZAT S	2009	Annu Rev Pathol2009，4，：	1
6	Pathogenetic mechanisms in thyroid follicular-cell neoplasia显示文摘	Kondo T Ezzat S Asa SL	2006	Nat Rev Cancer2006，6，4：	1
7	Pathogenetic mechanisms in thyroid follicular-cell neoplasia 显示文摘	Kondo T Ezzat S Asa SL	2006	Nature Reviews Cancer2006，6，4：	1
8	Thyroid calcification and its association with thyroid carcinoma 显示文摘	Khool ML Asa SL Witterick IJ	2002	Head Neck2002，24，7：	1
9	Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone- releasing hormone- producing bronchial carcinoid显示文摘	Ezzat S Asa SL Stefaneanu L	1994	J Clin Endocrinol Metab1994，78，：	1
10	Follicular epithelial dysplasi- a of the thyroid: morphological and immunohistochemical charac- terization of a putative preneoplastic lesion to papillary thyroid car- cinoma in chronic lymphocytic thyroiditis 显示文摘	Chui MH Cassol CA Asa SL	2013	Virchows Arch2013，462，5：	1
11	Epidermal growth factor and its receptor(FGF R) in human pituitary adenomas: FGF R correlates with tumor aggressiveness显示文摘	Leriche VK Asa SL Ezzat S	1996	J Clin Endocrinol Metab1996，81，2：	1
12	RET oncogene activation in papillary thyroid carcinoma显示文摘	Tallini G Asa SL	2001	Adv Ana Pathol2001，8，34：	1
13	Diagnostic- terminology antimorphologic criteria for cytologic diagnosis of thyroid lesion : a syn-opsis of the National Cancer lustilule Thyroid Fine-Needle Aspira-tion state of ihe Science Conference 显示文摘	Baloc-h ZW LiVolsi VA Asa SL ei al	2008	Diagn Cylopathol2008，36，6：	1
14	Controversies in papillary microcarcinomaof the tbyroid显示文摘	Piersanti M Ezzat S Asa SL	2003	Endocr Pa thol2003，14，3：	1
15	High molecularweight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumor显示文摘	Rapheal SL Mckeown-Eyssen G Asa SL	1994	Mod Pathol1994，7，1：	1
16	The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metas- tasis显示文摘	Liu W Cheng S Asa SL	2008	Cancer Res2008，68，19：	1
17	The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer 显示文摘	Kondo T Zhu X Asa SL	2007	Clin Cancer Res2007，13，16：	1
18	Thyroid calcification andits Association with thyroid carcinoma显示文摘	Khool ML Asa SL Witterick J	2002	Head Neck2002，24，：	1
19	The MEN-1 gene is rarely down-regulated in pituitary adenomas显示文摘	Asa SL Somers K Ezzat S	1998	J Clin Endocrinol Metab1998，83，9：	1
20	Pituitary adenoma with 'honeycomb Golgi' appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease 显示文摘	Sano T Kovacs K Asa SL etal	2002	Endocr Pathol2002，13，2：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示